Establishment Labs® Appoints Taylor Harris to Board of Directors
Establishment Labs appointed Taylor Harris to its Board of Directors, adding over 25 years of experience in healthcare finance and executive leadership to the company. Harris previously served as CEO of Cutera and CFO of MyoKardia, guiding the latter through its $13.1 billion acquisition by Bristol Myers Squibb, and currently sits on the board of Procept BioRobotics.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.